Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9068731 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Efficacy Study of Omalizumab in Cholinergic Urticaria
Condition: Cholinergic Urticaria
Interventions: Biological: Active;   Biological: Placebo;   Biological: Open labeled

Study has passed its completion date and status has not been verified in more than two years.